Skip to main content

Raiffeisen Bank International AG

Bank

Position in LLY — ELI LILLY & Co

CIK 2044885 VIENNA, C4

Position in LLY

as of Jun 30, 2026 · filed Aug 3, 2026
Position Value
$155,341,789
+$30,179,488 QoQ
Shares Held
129,513
-4.8% QoQ
Ownership
0.014%
of shares outstanding
% of Portfolio
1.81%
of 13F equity value
Holder Rank
#301
of 4,605 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority Sole 91% Shared 0% None 9%

Common Shares in LLY Over Time

Shares Held

Position Value (USD)

Derivatives in LLY

reported options exposure · as of Jun 30, 2026
CallValue
$239,886
CallShares
200
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Raiffeisen Bank International AG holds $427,125,963 across 9 Drug Manufacturers - General names. LLY ranks #1 (36.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 LLY
ELI LILLY & Co
This page
129,513 $155,341,789

All Filings in LLY

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $155,341,789 129,513
2026-06-30 $239,886 200
2026-03-31 $183,954 200
2026-03-31 $125,162,301 136,080
2025-12-31 $214,936 200
2025-12-31 $152,484,209 141,888
2025-09-30 $115,383,149 151,223
2025-09-30 $152,600 200
2025-06-30 $113,223,614 145,246
2025-03-31 $137,807,212 166,855
2024-12-31 $131,372,012 170,171